The first shift is federal. By mid-2025 the National Institutes of Health had terminated roughly 2,300 grants worth close to $3.8 billion, including cardiovascular trials, with more than 74,000 trial participants affected (AAMC, 2025; STAT, November 2025). When public science money contracts, the largest private funder of heart and stroke research inherits a role it did not ask for and has not yet claimed out loud.
The second shift is the donor base. Total United States giving reached a record $592.5 billion in 2024, yet the number of households that give has fallen for five straight years and donor retention sits near 31.9 percent (Giving USA 2025; SSIR, 2025). Only 18.3 percent of Americans report high trust in the charities they support, even as 42 percent say they are open to giving more if asked (Give.org Donor Trust Report, 2025).
Younger donors give on transparency and on the word of people they follow, not on legacy reputation (PNC, 2025). A third pressure sits on top of both. A federal health movement now scrutinizing nutrition authorities and their corporate ties has put the funding question back in the headlines (Straight Arrow News, 2025). For a brand whose authority is its asset, the timing concentrates the risk.